載入...
Postmarket safety of drugs approved by Health Canada on the basis of clinical and surrogate outcomes: a cohort study
BACKGROUND: Health Canada approves drugs on the basis of evidence from clinical trials using clinical or surrogate outcomes. This study compares the postmarket safety of these 2 groups of drugs. METHODS: Information about whether clinical or surrogate outcomes were used and the date of market approv...
Na minha lista:
| 發表在: | CMAJ Open |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
8872147 Canada Inc.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593464/ https://ncbi.nlm.nih.gov/pubmed/26442227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20150023 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|